Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | PFDN2 |
| Upstream (Parents) |
|---|
| (<<) AIFM1 → PFDN2 |
| (<<) AKAP12 → PFDN2 |
| (<<) CDK7 → PFDN2 |
| (<<) FADS2 → PFDN2 |
| (<<) HRAS → PFDN2 |
| (<<) HSP90AA1 → PFDN2 |
| (<<) HSPB1 → PFDN2 |
| (<<) PDIA3 → PFDN2 |
| (<<) PKM2 → PFDN2 |
| (<<) PPP1CA → PFDN2 |
| (<<) PTMA → PFDN2 |
| (<<) RHOD → PFDN2 |
| (<<) RHOQ → PFDN2 |
| (<<) SOCS5 → PFDN2 |
| (<<) TAGLN2 → PFDN2 |
| (<<) TYK2 → PFDN2 |
| Downstream (Children) |
|---|
| PFDN2 → ARHGEF2 (>>) |
| PFDN2 → BCAR3 (>>) |
| PFDN2 → CCL24 (>>) |
| PFDN2 → CHST2 (>>) |
| PFDN2 → CNIH4 (>>) |
| PFDN2 → MAP3K4 (>>) |
| PFDN2 → PLA2G4C (>>) |
| PFDN2 → PLD3 (>>) |
| PFDN2 → PRKCSH (>>) |
| PFDN2 → RGS20 (>>) |
| PFDN2 → SFN (>>) |
| PFDN2 → SHFM1 (>>) |
| PFDN2 → UAP1 (>>) |
